Boehringer Ingelheim announced that the FDA has approved dabigatran to treat deep vein thrombosis and pulmonary embolism. Perspective fromStephan Moll, MD According to a company press release, the agency approveddabigatran(Pradaxa), an oral anticoagulant, for the treatment of DVT and PE in pa...
USES: Dabigatran is used to prevent stroke and harmful blood clots (such as in your legs or lungs) if you have a certain type of irregular heartbeat (atrial fibrillation). Dabigatran is also used to treat blood clots in the veins of your legs (deep vein thrombosis) or lungs (pulmonary ...
Treat patients with an eGFR > 50 mL/min/1.73 m2 with the dosage according to Table 1 [see Dosage and Administration (2.3)]. 2.5 Administration PRADAXA Capsules should be swallowed whole. PRADAXA Capsules should be taken with a full glass of water. Breaking, chewing, or emptying the content...
Learn how Pradaxa® (dabigatran etexilate capsules) can help lower your risk of stroke due to AFib not caused by a heart valve problem. Read for ISI, Med Guide and PI.
Due to lack of data in pediatric patients with an eGFR < 50 mL/min/1.73 m² and the risk of increased exposure, avoid use of PRADAXA Oral Pellets in these patients. Treat patients with an eGFR > 50 mL/min/1.73 m² with the dosage according to Tables 1 and 2 [seeDOSAGE AND ADMI...
Pradaxa was primarily developed to treat deep vein thrombosis and pulmonary embolisms. However, in some cases, it may also be used as a preventative treatment for those conditions in hip replacement surgery. What Is Deep Vein Thrombosis (DVT)?